For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding

✍ Scribed by Sherwood, M.; Piccini, J. P.

• Book ID: 115492983
• Publisher: BMJ Publishing Group
• Year: 2012
• Tongue: English
• Weight: 68 KB
• Volume: 17
• Category: Article
• ISSN: 1356-5524
• DOI: 10.1136/ebmed-2011-100343